Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

723
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
723
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

287
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
287

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Structured Computational Roadmap for Lipidomics in R: Reproducible Workflows from Raw Data to Functional Insight.

Metabolites·2026
Same author

Human-in-the-Loop Artificial Intelligence: A Systematic Review of Concepts, Methods, and Applications.

Entropy (Basel, Switzerland)·2026
Same author

CpGene: a web application for epigenetic signature identification from DNA methylation arrays.

Bioinformatics (Oxford, England)·2026
Same author

Merging multimodal digital biomarkers into "Digital Neuro Fingerprints" for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI.

Frontiers in digital health·2026
Same author

AI agents in Alzheimer's disease management: challenges and future directions.

Frontiers in aging neuroscience·2026
Same author

Artificial intelligence analysis of minimally invasive surgery data.

Journal of robotic surgery·2026

Related Experiment Video

Updated: Oct 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Emerging Machine Learning Techniques for Modelling Cellular Complex Systems in Alzheimer's Disease.

Aristidis G Vrahatis1, Panagiotis Vlamos2, Antigoni Avramouli2

  • 1Department of Informatics, Ionian University, Corfu, Greece. arisvrahatis@uth.gr.

Advances in Experimental Medicine and Biology
|January 1, 2022
PubMed
Summary

Machine learning and network science offer powerful tools for understanding complex diseases like Alzheimer's disease (AD). This study explores how these methods, particularly gene regulatory network (GRN) construction, can clarify AD mechanisms.

Keywords:
Gene regulatory networksMachine learningNetwork biologyscRNA-seq data

More Related Videos

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

743

Related Experiment Videos

Last Updated: Oct 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

743

Area of Science:

  • Biomedical Big Data Analysis
  • Computational Biology
  • Network Science

Background:

  • The biomedical field generates vast amounts of data, necessitating advanced analytical tools.
  • Machine learning (ML) is crucial for interpreting complex biological processes and diseases by building predictive models.
  • Network science and ML methodologies are vital for studying complex cellular systems and diseases like Alzheimer's disease (AD).

Purpose of the Study:

  • To analyze the opportunities and challenges at the intersection of machine learning and network biology.
  • To investigate the impact of these integrated approaches on the biological interpretation and clarification of diseases, with a focus on AD.
  • To highlight the potential of emerging ML techniques, specifically ensemble tree-based methods, for deciphering complex disease mechanisms.

Main Methods:

  • Utilizing omics data to construct gene regulatory networks (GRNs) that capture molecular-level information.
  • Applying machine learning techniques, with a focus on ensemble tree-based methods (classification and regression).
  • Analyzing the integration of network science and ML for modeling complex cellular systems relevant to AD.

Main Results:

  • Gene regulatory network (GRN) construction using omics data and ML can provide comprehensive molecular insights into diseases.
  • Ensemble tree-based ML techniques show promise for classification and regression tasks in complex biological modeling.
  • The synergy between ML and network biology offers a pathway to unraveling intricate disease mechanisms.

Conclusions:

  • The integration of machine learning and network biology, particularly through GRN analysis, presents significant opportunities for understanding complex diseases like AD.
  • Emerging ML methodologies, especially ensemble tree-based approaches, are key to deciphering the complex cellular systems involved in AD.
  • This interdisciplinary approach has the potential to significantly advance the biological interpretation and clarification of AD pathogenesis.